Spirulina and Protein Citrullination

PAD Enzymes

Peptidylarginine deiminases (PAD1-6) convert peptidyl arginine to peptidyl citrulline, requiring calcium activation. PAD2 and PAD4 are widely expressed; PAD4 specifically citrullinates histones during NETosis. Physiological citrullination occurs in skin keratinization and myelin synthesis.

Citrullinated Antigens and ACPA

Anti-citrullinated protein antibodies (ACPA, measured as anti-CCP) are the most specific RA biomarker, present in 70% of patients years before symptom onset. Periodontal Porphyromonas gingivalis PAD generates citrullinated antigens that cross-react with self-proteins, providing a microbial trigger hypothesis.

Spirulina's Effects on Citrullination

Spirulina reduces neutrophil NETosis (covered separately), which limits PAD4-driven histone citrullination and citrullinated antigen release. Phycocyanin's anti-inflammatory effects on synovial macrophages reduce intracellular calcium dysregulation that activates PAD2.

RA Clinical Implications

While spirulina cannot replace DMARDs or biologics in established RA, its effects on citrullinated antigen burden, periodontal inflammation (a known RA trigger), and gut dysbiosis-driven autoimmunity provide adjunctive value. Animal RA models show 20-30% reduction in clinical scores with phycocyanin co-treatment.

Conclusion

Spirulina modulates citrullination through reduced NETosis, PAD2 activity dampening, and microbial trigger reduction. Clinical relevance in RA prevention/adjunct rather than primary treatment. The PAD-citrullination axis is emerging as a major autoimmunity mechanism — spirulina engages multiple upstream nodes.